Latest Diabetic retinopathy Stories
Study shows springtime is the peak month for pollen, cases of corneal dryness and irritation SAN FRANCISCO, April 23, 2015 /PRNewswire/ -- New ophthalmology research from the University of
LONDON, April 22, 2015 /PRNewswire/ -- This report on the retinal surgery devices market studies the current as well as future prospects of the market globally.
On-demand Launch Event Features the first U.S. Patient Injections of ILUVIEN ATLANTA, April 21, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
The new software technology is designed to seamlessly integrate into existing diabetic retinopathy care, while providing a cost-effective, highly scalable and safe solution to address the screening
LONDON, April 6, 2015 /PRNewswire/ -- Report DetailsAnalysis of revenues and R&D prospects for those eye drugs - you explore potentialsWhat's the future for treating disorders
LONDON, March 26, 2015 /PRNewswire/ -- Report Details Analysis of revenues and R&D prospects for those eye drugs - you explore potentials What's the future
Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., March 25, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Intelligent Retinal Imaging Systems (IRIS), a retinal screening solution for primary care, has received clearance by the United States Food and Drug Administration (FDA), a distinction that comes
Millions of Americans Struggle with Conditions ALEXANDRIA, Va., March 3, 2015 /PRNewswire/ -- More than 39 million Americans suffer from severe vision impairment or a disorder that
TARRYTOWN, N.Y., Feb. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.